Is Bristol Myers Squibb (BMY) Still Undervalued After Its Recent Share Price Rebound? [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
See our latest analysis for Bristol-Myers Squibb. That rebound sits against a more muted backdrop, with the share price still showing a slightly negative year to date return and a modest 1 year total shareholder return. This suggests sentiment has only recently started to improve as investors reassess pipeline and earnings risk. If this recovery has you rethinking large pharma, it might be a good time to scan other established names in the space using our curated list of pharma stocks with solid dividends With earnings growing despite softer top line trends and the share price still lagging its longer term history, the key question now is whether BMY remains undervalued or if the recent rally already reflects its future growth. With Bristol-Myers Squibb last closing at $54.28 and the most followed narrative putting fair value nearer $53.55, expectations hinge on a richer future earnings profile despite weaker top line assumptions. The analysts have a consensus price target
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb: A Pharma Giant Trading Like Growth Is Over - It's Not [Seeking Alpha]Seeking Alpha
- Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb: Pharma Giant Still Undervalued And Printing Cash Despite Patent Cliff [Seeking Alpha]Seeking Alpha
- Bristol-Myers Squibb Surges Into Year-End: Why BMY Still Looks Undervalued [Seeking Alpha]Seeking Alpha
- Bristol-Myers Squibb: Still Undervalued And Generating 4.65% Dividend Yield [Seeking Alpha]Seeking Alpha
BMY
Earnings
- 10/31/25 - Beat
BMY
Sec Filings
- 11/18/25 - Form 8-K
- 11/12/25 - Form CERT
- 11/10/25 - Form 8-A12B
- BMY's page on the SEC website